Transcript
8/13/2019 Kidney Disease, Tugas Prof Fat
1/88
Diseases of the Renal
System
dr.Agustin Faizah
8/13/2019 Kidney Disease, Tugas Prof Fat
2/88
An estimated 13.1% of adults ages 20 or older
(26 million adults) have physiological evidence
of chronic kidney disease (CKD) the
National Health and Nutrition Examinations
Survey between 1999 and 2004.
The medical interventions for these diseases
are among the most expensive treatments.
Introduction
8/13/2019 Kidney Disease, Tugas Prof Fat
3/88
Renal
vein
Inferior
vena cava
Urinary
bladder
Urethra
Renal
artery
Kidney
Aorta
Ureter
Renal
pyramid
Renal
Cortex
Renalmedulla
Renal
Pelvis
Ureter
(b) Longitudinal section of a kidney
(a) Components of the urinary system
Anatomy
The Kidneys
8/13/2019 Kidney Disease, Tugas Prof Fat
4/88
8/13/2019 Kidney Disease, Tugas Prof Fat
5/88
The functioning unit of the kidney is called the nephron.
Each kidney consists of approximately 1.2 million nephrons.
Each nephron is made up of a glomerulus ,which is a capillarytuft located between two arterioles (the afferent and the
efferent)
The afferent arteriole carries blood to the glomerulus and the
efferent arteriole carries blood away from it. The nephron extends through three sections of the kidney
called the cortex, outer medulla, and inner medulla .
The cortex contains the glomeruli and the proximal and distal
convoluted tubules. The medulla consists of the collecting ducts, loops of Henle,
and vasa recta.
8/13/2019 Kidney Disease, Tugas Prof Fat
6/88
The primary functions of the kidney :1. Maintenance of homeostasis through control of fluid, pH, and
electrolyte balance and blood pressure.
2. Excretion of metabolic end-products and foreign substances.
3. The production of enzymes and hormones.
Urine formation is a crucial component in the maintenance ofhomeostasis.
The glomerulus the first step in urine formation occurs filters largeproteins and blood cells The ultrafiltrate , is similar in composition tothe blood.
The tubules the second phase of urine production most of its
components are reabsorbed (amino acids, glucose, selective minerals, andwater)
Vasopressin controls the final phase of urine production, as it directsconcentration of urine and assists in maintaining overall fluid balance .
Urine osmolality can vary widely from 500 mOsm to 1200 mOsm. Volumevaries as well; as little as 500 mL or as much as 12 liters of urine can be
produced to maintain normal homeostasis.
Physiological Functions
8/13/2019 Kidney Disease, Tugas Prof Fat
7/88
Sodium is reabsorbed in the proximal tubule under theinfluence of aldosterone.
If serum sodium levels are elevated, sodium is
exchanged with potassium so that homeostasis isrestored.
The kidney additionally plays a significant role in bloodpressure control. Cardiac output and blood pressureare dependent on plasma volumeVasopressin,
secreted by the pituitary gland. The formation of urine also serves as the route for
excretion of waste products, including the by-productsof metabolism such as uric acid, creatinine, and urea.Other wastes excreted are drugs and environmentaltoxins.
The kidneys role in controlling both hydrogen andbicarbonate ions is a critical component of themaintenance of Ph homeostasis.
8/13/2019 Kidney Disease, Tugas Prof Fat
8/88
8/13/2019 Kidney Disease, Tugas Prof Fat
9/88
The kidney also produces important enzymes andhormones.
Renin, is produced by the kidney and isnecessary for the initiation of the renin-angiotensin control of fluid balance.
The hormones 1,25-dihydroxycholecalciferol anderythropoietin are also synthesized by the kidney.
The active form of vitamin D is synthesized in thekidney after the inactive direct precursor 25-hydroxycholecalciferol, 25(OH)D3) is hydroxylatedin the liver.
Erythropoietin (EPO) is a glycoprotein synthesizedin the kidneys that stimulates erythropoiesis inthe bone marrow.
8/13/2019 Kidney Disease, Tugas Prof Fat
10/88
Most commonly, kidney function is measured bythe glomerular filtration rate (GFR) measurethe rate at which substances are cleared from the
plasma by the glomeruli.
The normal GFR is 135200 liters per day. Of thislarge volume, 98% to 99% of filtrate is reabsorbed
with urine output, usually averaging 12 liters perday.
The GFR is used to evaluate kidney health,estimate the severity of diagnosed disease, and
monitor kidney disease progression.
Laboratory Evaluation of Kidney Function
8/13/2019 Kidney Disease, Tugas Prof Fat
11/88
The two equations most frequently cited are the
Modification of Diet in Renal Disease (MDRD)
equation andthe Cockcroft-Gault equation.The Cockcroft-Gault equation:
GFR = [(140 - age) x body weight (kg) x 0.85 if female]
72 x serum creatinine (mg/dL)]
Modification of Diet in Renal Disease (MDRD) equation:
GFR = 170 x serum creatinine x age x (0.762 if female) x
(1.20 if black race) x BUN x serum albumin
8/13/2019 Kidney Disease, Tugas Prof Fat
12/88
The clinical definition of CKD includes a long-term reduction in GFR, decreased creatinineclearance, and a corresponding increase inserum creatinine concentration.
Other biochemical assessments : tubularfunction tests, microscopic evaluation of theurine , radiological evaluation (intravenous
pyelogram (IVP), renal ultrasonography, renalradionuclide imaging, computing tomography,MRI, renal arteriogram), and biopsy of theorgan.
Chronic Kidney Disease
8/13/2019 Kidney Disease, Tugas Prof Fat
13/88
Signs and symptoms associated withinadequate kidney function to perform thenormal homeostatic control.
Advanced impairment of kidney functionresults in edema, metabolic acidosis,
hyperkalemia, anemia, uremia, azotemia,hyperphosphatemia, oliguria, hypertension,and bone and mineral disorders.
Pathophysiology Overview
8/13/2019 Kidney Disease, Tugas Prof Fat
14/88
CKD Response to Low Serum Calcium
and/or High Phosphorus
8/13/2019 Kidney Disease, Tugas Prof Fat
15/88
Chronickidney disease (CKD) is a syndrome ofprogressive and irreversible loss of theexcretory, endocrine, and metabolic functions
of the kidney secondary to kidney damage.
CKD progresses slowly over time, and there
may be intervals during kidney functions
remain stable.
Chronic Kidney Disease
Definition and Medical Diagnosis
8/13/2019 Kidney Disease, Tugas Prof Fat
16/88
The onset of renal failure is not usually
apparent until 50% to 70% of renal function
is lost.
The National Kidney Disease Education
Program (NKDEP) has defined CKD as
having a GFR of less than 60 mL/min/1.73
m2 for 3 months or longer and/or
albuminuria of more than 30 mg of urinaryalbumin per gram of urinary creatinine
8/13/2019 Kidney Disease, Tugas Prof Fat
17/88
NKDEP describes 5 stages of CKD :
- Stage 1 : kidney damage with normal or increased
GFR . GFR 90 mL/min/1.73 m2
- Stage 2 : kidney damage with mild decrease in GFR .
GFR: 6089 mL/min/1.73 m2
- Stage 3 : a moderate decrease in GFR.
GFR: 3059 mL/min/1.73 m2
- Stage 4 : a severe decrease in GFR.
GFR: 1529 mL/min/1.73 m2.
- Stage 5 : kidney function is inadequate to sustain life
and requires initiation of renal replacement
therapy. GFR: 15mL/min/1.73 m2.
8/13/2019 Kidney Disease, Tugas Prof Fat
18/88
CKD is a growing health concern.
The incidence of CKD is very high among the U.S. adultpopulation.
An estimated 11.5% of adults ages 20 or older have
evidence of CKD (The National Health and NutritionExamination Survey)
The incidence of CKD is even higher among patients withdiabetes mellitus, cardiovascular disease, andhypertension.
19902000: the number of persons with kidney failurerequiring dialysis or transplantation more than doubled
2006: > 500,000 individuals in the U S were receivingdialysis.
Epidemiology
8/13/2019 Kidney Disease, Tugas Prof Fat
19/88
Diabetes, hypertension, and glomerulonephritis arethe leading causes of kidney failure.
The following additional causes and risk factors :
EthnicityAfrican-Americans 4x white Americans
Native Americans 2x white AmericansHispanic Americans 2x non-Hispanic
whites
Family history .
Hereditary factors such as polycystic kidney disease (PKD)
A direct and forceful blow to the kidneys.
Prolonged consumption of over-the-counter painkillersthat combine aspirin, acetaminophen, and other
medicines such as ibuprofen.
Etiology
8/13/2019 Kidney Disease, Tugas Prof Fat
20/88
How Does Diabetes Lead to CKD?
Diabetic nephropathy is the most common cause of CKD inUS. People with either type 1 or 2 diabetes are at increased
risk. The risk is greater if blood sugars are not controlled. The earliest detectable change in the course of diabetic
nephropathy is a thickening in the glomerulus.
Increasing numbers of glomeruli are destroyed andincreasing amounts of albumin are excreted, can be
detected by a urinalysis. As the number of functioningnephrons declines, each remaining nephron must clear anincreasing solute load.
Eventually, the limit to the amount of solute that can becleared is achieved and the concentration in body fluids
increases, leading to azotemia and uremia. Because the progression is slow (microalbuminuria can
continue up to 510 years before other symptomsdevelop), the body can partially adapt to the changes.
8/13/2019 Kidney Disease, Tugas Prof Fat
21/88
The goal of medical and nutritional management of kidneydisease is to treat the underlying renal pathophysiology inorder to delay the progression of the disease.
Medical and nutritional care correlates with the level ofkidney dysfunction.
Progression of the disease is highly individualized, and manypatients may remain at these initial stages for months toyears.
When CKD progresses to end-stage renal disease (ESRD orCKD stage 5) and harmful wastes build up in the blood, bloodpressure rises, and excess fl uid is retained, more extensive
treatment is needed to replace the work of the kidneys. Treatment options include hemodialysis, peritoneal dialysis,
and kidney transplantation.
Treatment
8/13/2019 Kidney Disease, Tugas Prof Fat
22/88
Dialysis
Dialysis is a renal replacement procedure that removes excessiveand toxic by-products of metabolism from the blood, thus replacingthe filtering function of healthy kidneys.
It can maintain life once CKD progresses to the end stage, eventhough endocrine and metabolic functions of the kidney are nottotally replaced.
The decision to initiate dialysis depends on the severity ofsymptoms.
Symptoms considered to be definite indications for dialysis therapy
include pericarditis, uncontrollable fluid overload, pulmonary
edema, uncontrollable and repeated hyperkalemia, coma, and
lethargy. Less severe symptoms such as azotemia, nausea, and vomiting
require a subjective determination that takes into consideration thepatientsquality of life.
8/13/2019 Kidney Disease, Tugas Prof Fat
23/88
Currently two major types of renal replacementtherapy are used for patients with CKD Stage 5:
hemodialysis (HD) and peritoneal dialysis (PD).The most common method is hemodialysis.
Selection the type of dialysis based on severalfactors, including underlying kidney disease and
other comorbid factors such as cardiovasculardisease, age, family support, and proximity to adialysis center.
Regardless of the modality, both methods requirea selective semipermeable membrane that allowspassage of water and small-to middle-molecularweight molecules and ions but excludes large-
molecular weight molecules such as proteins.
8/13/2019 Kidney Disease, Tugas Prof Fat
24/88
The selective membrane is a man-made dialyzer sometimesreferred to as an artificial kidney.
The most common types are the hollow fiber and parallel-plate dialyzers.
Patients receiving hemodialysis first need to undergo a
procedure that allows continual access to the bloodstream. The preferred permanent access site is an arteriovenous
fistula (AVF), created surgically by fashioning in the forearmsubcutaneous joining of the radial artery and the cephalicvein
The AV fistula requires four to six weeks to become fullyfunctional. The subclavian route may be used temporarily ifHD is required before the AV fistula is ready for use.
Hemodialysis
8/13/2019 Kidney Disease, Tugas Prof Fat
25/88
While blood passes through the dialyzer,dialysate simultaneously passes around the
artificial membrane.
Waste products and excess electrolytes fromthe blood to the dialysate via diffusion,
ultrafiltration, and osmosis. The filtered bloodthen returns to the patient through the venousside .
Hemodialysis treatments are typically
prescribed three times a week for an averageof 4 hours per treatment
8/13/2019 Kidney Disease, Tugas Prof Fat
26/88
Although most hemodialysis treatments are doneat a dialysis center, home treatments can be an
option for some patients.
Daily home hemodialysis (DHHD) is conductedfive to seven days per week for two to three
hours at a time, and nocturnal homehemodialysis (NHHD) is performed three to sixnights per week during sleep.
The major advantage of home dialysis is the
ability to set ones own schedule; however, it isnecessary to have a trained partner and it mayalso be stressful to the patientsfamily.
8/13/2019 Kidney Disease, Tugas Prof Fat
27/88
Example of a Hemodialysis System
8/13/2019 Kidney Disease, Tugas Prof Fat
28/88
Access to the patientsblood supply is gained via a catheter ofsilicone rubber or polyurethane, placed surgically into theperitoneal cavity.
Dialysate is introduced into the peritoneum through theperitoneal catheter.
Solutes from the plasma circulating in the vessels and
capillaries perfusing the peritoneal wall pass across theperitoneal membrane into the dialysate, which issubsequently removed and discarded.
The dialysate for PD is available with a range of dextroseconcentrations that alter its osmolality and assist in fluidremoval.
The dwell time (i.e., how long the dialysate remains in theperitoneum) and the number of exchanges (i.e., how manybags of dialysate and the total volume of each used intwentyfour hours) also aff ect the amount of fl uid and soluteremoval.
Peritoneal Dialysis
8/13/2019 Kidney Disease, Tugas Prof Fat
29/88
Peritoneal Dialysis
8/13/2019 Kidney Disease, Tugas Prof Fat
30/88
Renal Transplantation
For an organ transplant to occur, theimmunological characteristics of the donatedorgan must be matched with the recipientsmedical and immunological characteristics.
The role of the major histocompatibility complex
(MHC) in determining acceptability for atransplanted organ was discussed.
MHC antigens play an important role intransplant rejection.
The immune system attacks the transplanted cellspresenting MHC antigens that are different fromthose found on the recipientstissues.
8/13/2019 Kidney Disease, Tugas Prof Fat
31/88
A national databaseUnited Network for
Organ Sharingprovides the information andcoordination that allow the recipient to bematched with a potential donor.
After transplantation, patients are maintainedon a variety of immunosuppressive regimensto prevent rejection of the donated kidney.Immunosuppressive medications include
corticosteroids, cyclosporine, tacrolimus,mycophenolate mofetil, and sirolimus.
8/13/2019 Kidney Disease, Tugas Prof Fat
32/88
Medical nutrition therapy (MNT) is an essential componentof medical care for early, progressive, and end-stage CKD.
Malnu trition, cardiovascular disease, bone and mineraldisorders, and anemia are the most common complications
that accompany kidney disease. Each of thesecomplications requires both medical and nutritionalintervention.
Many patients with CKD also have comorbid conditionssuch as hypertension and diabetes mellitus that also
require medical nutrition therapy. Nutrition therapy for CKD can help prevent and manage
complications as well as slow progression of the diseaseand compensate for impaired renal function and/orlimitations of treatment modalities.
Nutrition Therapy for Chronic Kidney Disease
8/13/2019 Kidney Disease, Tugas Prof Fat
33/88
Nutrition Assessment
Malnutrition is very common in patients with CKD, especiallythose who are on dialysis. Evidence suggests that theprevalence of protein-energy malnutrition (PEM) ranges fromapproximately 20% to 70% among adult dialysis patients.
Signs and symptoms of malnutrition present when the GFR
declines to 30 mL/minute, and may progress to significantmalnutrition at a GFR of 10 mL/minute.
it is extremely important to evaluate the many complexfactors that contribute to poor nutritional status in patientswith CKD as part of a comprehensive nutrition assessment.
The dietary restrictions associated with CKD add to thepotential for inadequate nutrient intake. It is especiallyimportant to assess for usual dietary patterns and food intake,intolerance of specific foods, nutrient restrictions of the diet,and fear of eating wrongfoods.
8/13/2019 Kidney Disease, Tugas Prof Fat
34/88
In summary, a nutrition assessment of the CKD patient should include:
Review of the medical record for comorbid conditions, drug/nutrient
interactions, or potential issues with digestion and absorption of
nutrients.
Nutrition interview for usual food/nutrient intake as well as changes in
appetite, changes in food intake with the onset/ progression of CKD, and
changes in elimination (urine output and stool).
Interview to evaluate social barriers to adequate nutritionalintake.
Physical assessment, including height, weight, frame size, subjective
global assessment and physical signs/symptoms of nutrient deficits
Review of biochemical/laboratory indices that might be affected by CKDAssessment of current food intakekcalories, protein, fat, sodium,
potassium, calcium, phosphorus, fluid, vitamins, and minerals.
8/13/2019 Kidney Disease, Tugas Prof Fat
35/88
Nutrition Diagnosis
Given the complexity of nutrition implications associatedwith CKD, many nutrition diagnoses may be present.
The following is a list of possible nutrition diagnoses forpatients with CKD:
Inadequate energy intake
Inadequate oral/food beverage intake
Excessive fluid intake
Malnutrition
Excessive protein intake
Excessive mineral intake (potassium, phosphorus,sodium) Altered GI function
Altered nutrition-related laboratory values
8/13/2019 Kidney Disease, Tugas Prof Fat
36/88
Food-medication interaction
Involuntary weight loss Involuntary weight gain
Food and nutrition-related knowledge deficit
Disordered eating pattern
Limited adherence to nutrition-related
recommendations
Undesirable food choices
Impaired ability to prepare foods/meals
Poor nutrition quality of life
Limited access to food
8/13/2019 Kidney Disease, Tugas Prof Fat
37/88
Nutrition Intervention
CKD is not a static medical condition. Disease
progresses through a series of stages.
The nutrition goals and intervention therefore
need to be individualized based on the stages
of CKD, and overall health status of thepatient.
Nutrient recommendations frequently
provided for patients receiving renalreplacement therapies (dialysis or
transplantation).
8/13/2019 Kidney Disease, Tugas Prof Fat
38/88
CKD Stages 1 and 2
Specific nutrition goals for stages 1 and 2 have notbeen identified, however nutrition therapy should
focus on the comorbid conditionsdiabetes,hypertension, and hyperlipidemiaand on slowing theprogression of potential cardiovascular disease.
Glucose control, blood pressure reduction, and lipid
management . Nutrition counseling recommendations include regular
assessment (at 13 month intervals) of the patientsnutritional status.
Interventions that maintain or improve nutritionalstatus during the progression of kidney disease areassociated with improved patient survival.
8/13/2019 Kidney Disease, Tugas Prof Fat
39/88
CKD Stages 3 and 4
The KDOQIclinical practice guidelines specifically foradults with CKD who are not on dialysis (Stage 4).These guidelines outline recommended: nutritionmeasures, protein intake, energy requirements, andnutrition counseling.
Nutrition measures identified for individuals with GFR
8/13/2019 Kidney Disease, Tugas Prof Fat
40/88
Recommendations for nutrition intervention for patientswith CKD (GFR
8/13/2019 Kidney Disease, Tugas Prof Fat
41/88
The ability of the kidney to excrete metabolic
products of protein, regulate acid/basebalance, produce adequate amounts of
erythropoietin, activate vitamin D, and
regulate calcium, phosphorus, potassium,
sodium, and fluid excretion diminishes
modifications in calcium, phosphorus,
vitamins, minerals, and fluid are frequently
necessary.
8/13/2019 Kidney Disease, Tugas Prof Fat
42/88
CKD Stage 5
The goals of nutrition therapy :
prevent malnutrition
minimize uremia and associated CKD complications(cardiovascular disease, anemia, secondaryhyperparathyroidism)
maintain blood pressure and fl uid status.
In general, the hemodialysis diet is high in protein andcontrols intake of potassium, phosphorus, fluids, and sodium.
Based on nutritional requirements, additional modifi cationsmay be needed for fat, cholesterol, and triglycerides.
Patients receiving peritoneal dialysis have a more liberalizeddiet than hemodialysis patientsthis diet is higher in protein,sodium, potassium (due to increased losses during the dialysisprocess), and fluid, but it is still limited in phosphorus.
8/13/2019 Kidney Disease, Tugas Prof Fat
43/88
Nutrient Recommendations for CKD
8/13/2019 Kidney Disease, Tugas Prof Fat
44/88
8/13/2019 Kidney Disease, Tugas Prof Fat
45/88
PROTEIN
Factors relating to higher protein requirements include:
(1) losses of approximately 10 to 12 grams free amino acids per day
and 5 to 15 grams per day of albumin
(2) altered albumin turnover
(3) metabolic acidosis, which increases amino acid degradation
(4) inflammation
(5) infection. The NKF K/DOQI guidelines on nutrition 1.2 grams of protein/kg
body weight for HD patients to ensure adequate intake of essentialamino acids.
At least 50% of the protein should be of high biological value.
The protein requirements for PD are slightly higher than for HD.During episodes of peritonitis (inflammation of the peritoneum), evenin mild cases, the dialysate protein losses increase by 50% to 100% toan average of 15 to 36 g/24 hours and have been reported to remainelevated for several weeks.
8/13/2019 Kidney Disease, Tugas Prof Fat
46/88
ENERGY
Adequate energy intake is important in order to
prevent catabolism and achieve optimal nutritionalstatus. Sufficient kcal from carbohydrates and fat mayhelp to prevent muscle and visceral protein from beingutilized as energy.
The energy recommendation from the K/DOQI
Nutrition Guidelines is based on the finding that energyexpenditure is similar to or slightly higher than that ofhealthy persons .
A lower caloric requirement has been shown to beadequate for older persons who are more sedentary.Caloric requirements should be adjusted accordinglyfor those with higher activity levels, those who areunderweight and those who display catabolic stress.
There are adjusted edema-free body weight for
8/13/2019 Kidney Disease, Tugas Prof Fat
47/88
There are adjusted edema free body weight for
Obese and Underweight patients to be used
when calculating protein and energy requirements
for underweight and obese patients.
8/13/2019 Kidney Disease, Tugas Prof Fat
48/88
FAT
In general, patients on HD and PD are at increasedrisk for CAD (coronary artery disease) and stroke.
Hemodialysis patients typically display normallow-density lipoprotein (LDL) cholesterol, lowhigh-density lipoprotein (HDL) cholesterol, and
elevated triglyceride levels. PD patients exhibit higher total serum cholesterol
levels as well as LDL levels. Triglyceride levels areespecially increased in PD patients due to the
absorption of glucose in the dialysate. It is recommended that both PD and HD patients
adhere to the nutrient composition guidelines ofthe therapeutic lifestyle changes (TLC) diet.
8/13/2019 Kidney Disease, Tugas Prof Fat
49/88
Therapeutic Lifestyle Changes for
Patients with CKD
8/13/2019 Kidney Disease, Tugas Prof Fat
50/88
POTASSIUM
The potassium restriction for HD and PD patients
varies, depending on the degree of kidney function,serum potassium levels, modality, and drug therapy.
For the most part, a diet that allows 50 to 70 mmol/dayor approximately 2 to 3 g/day of potassium iscommonly prescribed in HD.
Those who are oliguric or anuric are at an increasedrisk for hyperkalemia and should have a more stringentdietary restriction.
The target range for serum potassium is 3.56.0 mEq/L. Severe hyperkalemia (serum K greater than 7.0 mEq/L)
may precipitate fatal arrhythmias.
8/13/2019 Kidney Disease, Tugas Prof Fat
51/88
FLUID AND SODIUM
Fluid and sodium allowances are highly individualized andbased primarily on residual urine output and dialysis modality.
Other considerations include blood pressure control,interdialytic weight gains in HD patients, presence of edema,and congestive heart failure.
The interdialytic weight gain goal in HD patients should notexceed 5% of body weight.
Higher fluid gains can lead to sudden changes in blood volumeand hypotension during the hemodialysis treatment.
If patients become oliguric or anuric within the first 12months of hemodialysis 2 gram sodium diet with a fluidallowance of not more than 1 L (1000 mL) daily.
If urine output is greater than 1 L per day, the sodium and fluid allowance can be liberalized to approximately 2 to 4 gsodium per day and 2 L (2000 mL) of fluid per day.
8/13/2019 Kidney Disease, Tugas Prof Fat
52/88
Fluid and sodium requirements for patients onPD therapy are highly individualized and
largely based on ultrafiltration.
Ultrafiltration can remove 2 to 2.5 kg of fluidper day.
Fluid and sodium restriction for the PD patientincludes a fluid allowance of 2 L per day and asodium allowance between 2 and 4 g per day.
Fluid overload
shortness of breath,hypertension, congestive heart failure, andedema.
8/13/2019 Kidney Disease, Tugas Prof Fat
53/88
PHOSPHORUS
In early CKD hyperphosphatemia is preventedby an adaptive increase in renal excretion and
decreased phosphate reabsorption.
If the GFR : 20 - 30 mL/min/1.73 m2 Hyperphosphatemia.
Phosphorus restriction of 8001000 mg/day
or
8/13/2019 Kidney Disease, Tugas Prof Fat
54/88
CALCIUM
Dietary calcium requirements are higher in CKD.
Low serum calcium levels often accompany CKDdue to alterations in vitamin D metabolism,decreased absorption of calcium from the gut,and elevated phosphorus levels.
Foods high in calcium are restricted, because theytend to be high in phosphorus as well.
Calcium supplements should be taken on empty
stomachbetween meals or at bedtime) . The amount of calcium from the diet plus the
amount found in supplements should not exceed2,000 mg per day.
8/13/2019 Kidney Disease, Tugas Prof Fat
55/88
VITAMIN SUPPLEMENTATION
Supplementation of water-soluble vitamins due toincreased losses during dialysis,
anorexia, and poor dietary intake is typically indicatedfor HD and PD patients.
In general, the renal vitamin contains B vitamins,folic acid, and vitamin C.
Fat-soluble vitamins and minerals are not included.Preparations containing vitamin A or high doses ofvitamin C should be avoided.
Serum levels of B1 (thiamin), B2 (ribofl avin),pantothenic acid, and biotin are typically normal.
Biotin supplementation of 10 mg/day has been foundto be helpful in treating patients with peripheralneuropathy, encephalopathy, and intractable hiccups.
8/13/2019 Kidney Disease, Tugas Prof Fat
56/88
Vitamin C should be limited to no more than 100mg per day.
serum vitamin A levels are elevated in HD and PDpatientssupplementation is not necessary.
Very little is known about the long-term effects ofvitamin E
Vitamin K supplementation may be needed forthose patients receiving antibiotic therapy, sincethe antibiotics may destroy the bacteria found inthe gastrointestinal tract (these bacteria are aprimary source of vitamin K).
Most HD patients receive anti-coagulationtherapy caution must be taken due to vitaminKsrole in promoting clot formation.
8/13/2019 Kidney Disease, Tugas Prof Fat
57/88
MINERAL SUPPLEMENTATION
Magnesium is excreted by the kidneys.
magnesium levels are usually normal to mildly elevated indialysis patients and not generally supplemented.
Iron deficiency is common , due to the kidneys inability tomake adequate erythropoietin for production of red bloodcells
Most patients will require iron supplementation, which isindividualized depending on serum markers of ferritin, iron,total iron binding capacity, and transferrin saturation.
Some studies have indicated that impaired taste sensation,
loss of appetite, and sexual dysfunction may beameliorated with zinc supplementation.
The allowance for zinc is the same as the RDA: 15 mg perday.
8/13/2019 Kidney Disease, Tugas Prof Fat
58/88
Nutritional Requirements of the Posttransplant Patient
The goal in the acute posttransplant period is :- to manage the increased metabolic demands of
transplant surgery, obesity, blood pressure, insulin
resistance, diabetes, and hyperlipidemia
- maintenance of electrolyte balance
- maximized bone health.
Nutrition therapy for kidney transplant patients
differs between the acute phase (up to 8 weeksfollowing transplant) and the chronic phase(beginning the ninth week following transplant).
8/13/2019 Kidney Disease, Tugas Prof Fat
59/88
Monitoring and Evaluation
8/13/2019 Kidney Disease, Tugas Prof Fat
60/88
Monitoring and Evaluation
Outcome measures for MNT in the CKD population can be
classified as clinical or patient behavioral outcomes see
table
8/13/2019 Kidney Disease, Tugas Prof Fat
61/88
Definition:
ARF is a disorder characterized by abrupt cessation or reduction inGFR an accumulation of nitrogenous wastes.
Epidemiology
The prevalence of ARF is estimated at 1% for all hospitalizedpatients, 3% to 5% for general medical-surgical patients, 5% to 25%for those in intensive care units, 5% to 20% for open-heart surgery
patients, 20% to 60% for those with severe burns. Death occurs in 40% of nonsurgical patients with severe ARF, 80%
of surgical patients is associated with the degree ofhypercatabolism and infection.
Acute Renal Failure.
8/13/2019 Kidney Disease, Tugas Prof Fat
62/88
Etiology
The three major types of acute renal failure are : prerenal azotemia,
intrinsic and obstructive. Prerenal azotemia :
reduce perfusion to the kidney ( ex: severe dehydration, circulatorycollapse, fluid losses from the GI tract or from extensive woundssuch as seen in burns).
Acute tubular necrosis (ATN) is the ischemia damages epithelial
cells, causing necrosis of the kidney , potentially irreversible renalfailure.
Intrinsic ARF :
refers to damage to the anatomical structure of the kidney occurafter exposure to toxins such as antibiotics, chemotherapy, orcontrast dyes used in various imaging tests, infection such asglomerulonephritis
Obstructive failure results from a blockage of the ureter or neck of thebladder could result in obstruction include kidney stones, bloodclots, or a tumor.
Pathophysiology
8/13/2019 Kidney Disease, Tugas Prof Fat
63/88
Pathophysiology
In prerenal ARF the lack of blood flow to
kidneys reduction the filtrate pressure in theglomerulus uremic symptoms.
If blood flow is not restored necrosis of thecells .
Liu (2010)4 phases of ARF:1. Initiation (when GFR declines)
2. Extension (when ischemia and inflammatorydamage continue)
3. Maintenance (when GFR is at its lowest level)
4. Recovery (when epithelial cells regenerate).
8/13/2019 Kidney Disease, Tugas Prof Fat
64/88
Clinical Manifestations
Normal urine output: 1 to 1.5 L per day.
GFR declines and reaches its lowest level: ARF
patients
may produce
8/13/2019 Kidney Disease, Tugas Prof Fat
65/88
Decreased levels of serum potassium,magnesium, and phosphorus may also occur asa result of intracellular shifts associated withcarbohydrate delivery and anabolism.
Hypophosphatemia also occurs in the refeedingsyndrome, malnutrition, and diuretic therapy.
Serum levels of potassium, magnesium, and
phosphorus should be monitored frequentlyto assess the need for additionalsupplementation.
Nitrogen (BUN) and creatinine are elevated in ARF
8/13/2019 Kidney Disease, Tugas Prof Fat
66/88
Nitrogen (BUN) and creatinine are elevated in ARF,
although the ratio of BUN to creatinine may be
normal (10:1 or higher).
Insufficient dietary kcal and protein and altered
blood levels of proteases contribute to high levels of
protein catabolism.
Dialysis may be required to remove metabolic wastesand excess water.
When recovery of renal function is expected to take
several weeks, or when wasting is severe, aggressive
dialysis is often recommended.
Medical and nutrition management typically aim to
maintain BUN in the range of 80 to 100 mg/dL.
8/13/2019 Kidney Disease, Tugas Prof Fat
67/88
Treatment
Treatment options and nutrition support should bebased on ;
- the underlying cause of renal failure,
- the specific metabolic changes within each patient,
- other complications associated with the illness. Generally, continuous renal replacement therapy
(CRRT) is the mode of treatment for an individual withARF.
CRRT is the term for several different modes ofproviding dialysis over a continuous period that allowfor a significant amount of fluid (12 L/hour) to beremoved.
8/13/2019 Kidney Disease, Tugas Prof Fat
68/88
Nutrition Therapy for Acute Renal Failure
It is common for the nutritional status of patients
with ARF to decline within a short period of time,owing to :nitrogen losses (up to 30 g per day), which lead to loss
of lean body mass;
toxicity-related symptoms (anorexia, nausea,vomiting, bleeding);
loss of essential and nonessential amino acids
loss of plasma proteins during intervention dialysistherapy;
metabolic disturbances (impaired glucose utilizationand protein synthesis) from uremia. Energy andprotein
malnutrition
8/13/2019 Kidney Disease, Tugas Prof Fat
69/88
Nutrition Intervention
Energy and protein intake should meet the patients
requirementsdepends on the patients nutritional status,catabolic rate, residual GFR, and medical and/or surgicalinterventions (e.g., type of dialysis therapy).
Protein, amino acids, and energy substrates may not beutilized efficientlydifficult to maintain or improve the
nutrition status of these patients by enteral or parenteralsupport.
When feasible, patients with ARF should receive oralnutrition.
If a patient cannot eat adequately, other forms of nutrition
support should be pursued. Enteral nutrition support with standard formulations should
be considered first for patients with ARF. If necessary, specificformulas with lower electrolytes can be considered.
8/13/2019 Kidney Disease, Tugas Prof Fat
70/88
General recommendations f or protein are 0.6(no dialysis) to 1.4 (dialyzed) g/kg/d.
Adequate kcal should also be provided (30 to 35kcal/kg/d).
Protein sources containing both essential andnonessential amino acids should be provided.
The patients nutrition and metabolic status andthe renal diagnosis determine the exact dose.
For patients receiving acute hemodialysis, the
recommendation is 1.2 to 1.4 g/kg of protein. For those on CRRT, protein requirements should
be estimated at 1.5 to 2.0 g/kg.
Traditional recommendations indicate that when
8/13/2019 Kidney Disease, Tugas Prof Fat
71/88
Traditional recommendations indicate that whenenergy requirements cannot be measured by indirectcalorimetry, can be estimated using 25 to 35kcal/kg.
ASPEN guidelines: In all ICU patients receiving PN,mild underfeeding should be considered at leastinitially.
After energy requirements are determined, 80% of
these requirements should serve. The total fluid intake depends on the amount of
residual renal function (i.e., whether the patient isoliguric or anuric) and f uid and sodium status.
Fluid intake can be calculated by adding 500 mL (forinsensible losses) to the 24-hour urine output.
Fluid and mineral balance need to be carefullymonitored in ARF to prevent over hydration andelectrolyte disorders.
8/13/2019 Kidney Disease, Tugas Prof Fat
72/88
Total fluid input is recommended to equal output from
urine and all other measured sources (e.g., nasogastricaspirate or fistula drainage) plus 400 to 500 mL per day.
If the patient is catabolic weight can be allowed to dropby 0.2 to 0.5 kg per day to avoid excessiveaccumulation of fluid.
Records of daily intake and output, weight changes,serum electrolyte levels, and blood pressure forassessment of fluid tolerance and requirements.
Supplementation of minerals, electrolytes, and traceelements monitoring serum and urine to preventexcess or deficiency states .
8/13/2019 Kidney Disease, Tugas Prof Fat
73/88
Definition
NS is an abnormal condition that is marked by a deficiency ofalbumin in the blood and its excretion in the urine due to alteredpermeability of the glomerular basement membranes.
Epidemiology
About 2 : 10.000.
The prevalence is difficult to establish in adults because thecondition is usually a result of an underlying disease.
NS may occur at any age but is more prevalent in children than inadults.
In children it is most common between 1-4 y.o, males > females.
Nephrotic Syndrome
8/13/2019 Kidney Disease, Tugas Prof Fat
74/88
Etiology
NS can occur with many diseases :
- Primary glomerular diseaseglomerular
dysfunction, including many conditions with avariety
of genetic and environmental causes.- Focal segmental glomerulosclerosis (FSGS)
- Diabetic nephropathy
- an infection/drug toxic to the kidneys.- autoimmune diseases (IgA nephropathy or
systemic lupus erythematosus(SLE)).
8/13/2019 Kidney Disease, Tugas Prof Fat
75/88
Nephrotic syndrome is characterized by:
- proteinuria (urinary protein levels greater than
3.5 g per 1.73 m2 of body surface area per day),
- hyperlipidemia,- hypoalbuminemia
8/13/2019 Kidney Disease, Tugas Prof Fat
76/88
Oliguria or acute renal failure may develop because of
hypovolemia (a decrease in the volume of the circulatingblood) and diminished renal perfusion.
Orthostatic hypotension and even shock can be seen inpediatric patients.
Protein losses in adults with NS average about 6 to 8 gramsper day.
Albumin is the principal protein lost in urine, accounting forbetween 75% and 90% of urinary protein.
In adults, serum albumin levels may be less than 2 g/dL.
Micronutrients lost in the urine include those bound toplasma proteins such as zinc, copper, vitamin D, and iron.
8/13/2019 Kidney Disease, Tugas Prof Fat
77/88
Nephrotic syndrome has also been associated withincreased risk of atherosclerosis due to altered lipid
metabolism characterized : by cholesterol andtriglycerides , LDL , HDL N or
The reduction of lipoprotein lipase, an enzymeresponsible for lipoprotein metabolism, is thought to
be the reason for reduced clearance of these lipids. Atherogenic lipoprotein and fibrinogen levels due to
increased hepatic synthesiscardiovascular risk.
Hyperlipidemia alone can impair renal function .
Reducing lipid levels can slow down the progression ofrenal injury.
Treatment
8/13/2019 Kidney Disease, Tugas Prof Fat
78/88
Treatment
Medical treatment of nephrotic syndrome focuses onidentifying and treating the underlying cause, reducing
high cholesterol, blood pressure, and protein in the urinediet and drugs
ACE therapy reduces proteinuria and slows down theprogression of CKD.
ACE inhibitor and angiotensin receptor blockers (ARBs)
therapy, including combination therapy reduceproteinuria in diabetic nephropathy and idiopathicnephritic syndrome.
Proteinuria may also be decreased by lowering thepatientsmean arterial pressure to levels below 92 mm Hg .
Potassium levels should be checked in those with moderateto severe renal dysfunction, because ACE inhibitors mayexacerbate hyperkalemia
8/13/2019 Kidney Disease, Tugas Prof Fat
79/88
Nutrition Therapy for Nephrotic Syndrome
The goals:
- minimizing the effects of edema, proteinuria,
and hyperlipidemia
- replacing nutrients lost in the urine- reducing the risks of further renal progression
and atherosclerosis.
8/13/2019 Kidney Disease, Tugas Prof Fat
80/88
Nutrition Assessment
Evaluate biochemical measures of renal function
(GFR, BUN, creatinine), acid-base balance, lipidprofile, fluid and electrolyte balance, proteinstatus, and vitamin/mineral status.
energy and protein needs should be calculated
using usual or ideal body weight, becauseanthropometrics will be skewed due to thepresence of edema.
Dietary assessment will focus on usual dietary
intake with a careful evaluation of protein,phosphorous, calcium, potassium, and sodiumconsumption .
8/13/2019 Kidney Disease, Tugas Prof Fat
81/88
Nutrition Diagnosis
Include: increased nutrient needs, inadequate protein intake,excessive sodium intake, and food/nutrition knowledge defi cit
Nutrition Intervention
The nutrition therapy prescription components for NS aresummarized in Table .
Minimize edema include sodium restriction and diuretics.A
sodium restriction of 2000 mg or less per day Fluid intake is generally not restricted.
Current protein recommendations are 0.8 to 1.0 g/kg/day.Thislevel of intake is believed to decrease proteinuria without reducingserum albumin.
Several studies have suggested that soy protein or flaxseed-basedproteins may be more beneficial than high-quality proteins inreducing proteinuria, lowering lipid levels, and slowing down theprogression of renal .
There are no long-term studies to suggest the safety of low-proteindiets that provide less than 0.8 g/kg/day.
Nephrolithiasis
8/13/2019 Kidney Disease, Tugas Prof Fat
82/88
Definition
Kidney stones (renal lithiasis or nephrolithiasis) form as a result ofabnormal crystallization of calcium, oxalate, struvite, cystine,hydroxyapatite, or uric acid that is unable to be excreted normally in theurine.
Epidemiology
Nephrolithiasis affects almost one million individuals in the United Stateseach year.
men > women , varies depending on ethnicity and geographic region.
Ages : 20 - 30 years.77
Risk factors for kidney stones include family history, certain medical
conditions (hypercalciuria, hyperuricosuria, hyperoxaluria); and low urinevolume.
Hypercalciuria is the cause of more than 50% of all kidney stones.
Other causes of kidney stones include gout, excess intake of vitamin D,urinary tract infections and urinary tract blockages.
Nephrolithiasis
Pathophysiology
8/13/2019 Kidney Disease, Tugas Prof Fat
83/88
p y gy
Kidney stones generally consist of calcium salts,
cystine, uric acid, or struvite (a combination ofmagnesium, ammonium, and phosphate).
Generally, the development of kidney stones isnot directly related to any one cause.
Multiple factors may contribute .
Kidney stones typically do not cause anysymptoms until a stone acutely blocks urine flow.
The pain will migrate depending on the location ofthe stone.
Other symptoms : hematuria, nausea ,vomiting,pain with urination, and an urgency to urinate.
T t t
8/13/2019 Kidney Disease, Tugas Prof Fat
84/88
Treatment
Depends on whether or not the patient can
pass the stone on his or her own.
Although most patients can pass the stone
with plenty of fluids and pain medication,
hospitalization may be required in some casesif the pain is severe.
If the patient cannot pass the stone, there are
several procedures available: extracorporealshockwave lithotripsy (ESWL), percutaneous
nephrolithotomy, and ureterorenoscopy.
Nutrition Therapy for Nephrolithiasis
N t iti th i t ith i i i i th f t
8/13/2019 Kidney Disease, Tugas Prof Fat
85/88
Nutrition therapy can assist with minimizing the factorsthat may contribute to kidney stone formation.
A complete analysis of the stone composition is necessary
for the development of appropriate nutrition interventions.
Nutrition Assessment
Dietary assessment should focus on nutrient intake that
may affect the development of a specifi c stone composition.
Assessment of fluid intake is also a critical factor indevelopment of
appropriate nutrition prescriptions and interventions.
Nutrition Diagnosis
Include : excessive mineral intake, inadequate fluid intake,or food and nutrition-related knowledge deficit.
Nutrition Intervention
8/13/2019 Kidney Disease, Tugas Prof Fat
86/88
Nutrition Intervention
The objectives of nutrition therapy are tominimize the supersaturation of urinarycomponents associated with the formation ofstones and to prevent stones from recurring.
The most effective preventative treatment isto increase fluid intake by 3 L per dayshould be taken in divided doses, throughout
the day and night -- > will ensure a minimumurine output of 2 L/day.
8/13/2019 Kidney Disease, Tugas Prof Fat
87/88
a diet low in calcium would help prevent the
formation of calcium stones. However, it has
now been demonstrated that foods high in
calcium, including dairy products, can actually
prevent the formation of stones.
A possible explanation for this is that a
reduction in dietary calcium aids in the
intestinal absorption of oxalate, thus
increasing urinary super-saturation of calcium The goal with minimizing oxalate intake is to
decrease the bioavailability of oxalate.
8/13/2019 Kidney Disease, Tugas Prof Fat
88/88
The following foods should be avoided : beets,chocolate, cola, coffee/tea, nuts/nut butters,
berries, wheat bran, spinach, and rhubarb. Avoidance of greater than 2 grams of vitamin C
should also be advised.
For stones that are composed of uric acid,avoidance of foods high in purine isrecommended.
Foods high in purine include: animal protein,
seafood, meat extracts, consomme, gravies andorgan meats.
top related